3066 Real-world retrospective safety analysis of onabotulinumtoxina for the concomitant treatment of patients with spasticity and other therapeutic indications

• Angeli Mayadev,
• Ziyad Ayyoub,
• Atul Patel,
• Kim Becker Ifantides,
• Ahunna Ukahd Ukah,
• Mariana Nelson,
• Simona Battucci,
• Jodi Clancy-Stott,
• Theodore Brown

Affiliations

Angeli Mayadev

1Swedish Neuroscience Institute, Seattle, Washington, USA

Ziyad Ayyoub

2Rancho Los Amigos National Rehabilitation Center, Downey, California, USA

Atul Patel

3Kansas City Bone & Joint Clinic, Overland Park, Kansas, USA

Kim Becker Ifantides

4AbbVie, Irvine, California, USA

Ahunna Ukahd Ukah

5AbbVie, Irvine, California, USA

Mariana Nelson

4AbbVie, Irvine, California, USA

Simona Battucci

6AbbVie, Rome, Italy

Jodi Clancy-Stott

7Medical Affairs, AbbVie Pty Ltd, Sydney, NSW, Australia

Theodore Brown

8EvergreenHealth Kirkland, Kirkland, Washington, USA